TenderlineUK
Procurement Intelligence
Search
Find a TenderCancelled
Published 30 Jul 2025, 10:34 BST

Official UK procurement notice

NP38625 Compounded Aseptic Medicines

Official notice

Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) (NHS & healthcare)

Framework agreement4 lotsGoodsOpen procedure
Sectors: Medical Devices & Pharma (33) Delivery: Scotland (UKM)
Framework ceiling (notional)£21,944,507total for 4 lots · framework ceiling, not attributable revenue
Submissions closed 1 Sept 2025
Lots 4see the lot list below

What is being bought4 lots · detail below

Published requirement description

Supply of Compounded Aseptic Medicines to NHS Scotland.

CPV: Pharmaceutical products

How this framework works

From the published notice
Places
up to 4 suppliers

Lots and requirements (4)Procurement structure

4 lots · all with a published value · evaluation weights differ by lot
Lot #1Compounded Aseptic MedicinesCancelledRenewalPublished value£11,405,397

Supply of Compounded Aseptic Medicines to NHS Scotland.

The Authority intends to award this Lot as a single supplier framework.

Molecules included within this Lot are as follows:

CARBOPLATIN

CETUXIMAB

CYCLOPHOSPHAMIDE

PEMBROLIZUMAB

Full details of Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #2Compounded Aseptic MedicinesCancelledRenewalPublished value£5,914,986

Supply of Compounded Aseptic Medicines to NHS Scotland.

The Authority intends to award this Lot as a single supplier framework.

Molecules included within this Lot are as follows:

EPIRUBICIN

FLUOROURACIL

IRINOTECAN

METHOTREXATE

NIVOLUMAB

RITUXIMAB

Full details of Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #3Compounded Aseptic MedicinesCancelledRenewalPublished value£3,134,690

Supply of Compounded Aseptic Medicines to NHS Scotland.

The Authority intends to award this Lot as a single supplier framework.

Molecules included within this Lot are as follows:

BORTEZOMIB

CISPLATIN

DOCETAXEL

DOXORUBICIN

GEMCITABINE

INFLIXIMAB

OXALIPLATIN

TRASTUZUMAB

VINCRISTINE

Full details of Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #4Compounded Aseptic MedicinesCancelledRenewalPublished value£1,460,761

Supply of Compounded Aseptic Medicines to NHS Scotland.

The Authority intends to award this Lot as an un-ranked multi supplier framework to a maximum of three (3) Framework Participants.

Molecules included within this Lot are as follows:

BEVACIZUMAB

CYTARABINE

FLUOROURACIL PRE-FILLED PUMPS

INSULIN

METHOTREXATE

NATALIZUMAB

PACLITAXEL

PANITUMUMAB

TRASTUZUMAB

VEDOLIZUMAB

Full details of Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored

Lots publish different evaluation splits; there is no single procedure weighting.

LotQualityPriceSplit
1 · Compounded Aseptic Medicines40%60%
2 · Compounded Aseptic Medicines40%60%
3 · Compounded Aseptic Medicines40%60%
4 · Compounded Aseptic Medicines40%60%
Conditions of participation3
  • Suitability

    Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015

  • Economic & financial standing

    Where a Potential Framework Participant submits a tender for a specific Lot they are required to have a minimum annual turnover to cover the value for that Lot:

    Lot 1 - minimum of 11500000 GBP

    Lot 2 - minimum of 6000000 GBP

    Lot 3 - minimum of 3500000 GBP

    Minimum: (1) an extract from its audited accounts in respect of its most recent full financial year stating the turnover of the economic operator in respect of such financial year, such extract certified on its face by a solicitor or a chartered accountant as being a true copy of the orig…
  • Technical & professional ability

    a) Potential Framework Participants must be able to demonstrate the existence of a valid and current MHRA Manufacturing Specials License, or equivalent, under which all Goods tendered will be manufactured, at the date of submission of the tender;

    (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.

    (c) Potential Framework Participant's Goods must meet the product Specifications in the ITT

    (d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond

    Minimum: (a) Confirmation of existence of a valid and current MHRA Manufacturing Specials License, or equivalent, under which all Goods tendered will be manufactured for all tendered Goods at the date of submission of the tender should be included in the Qualification Envelope of the ITT …
What this means for your bid
  • Price carries 60 points on every lot: a 10% discount moves about 6 points.
  • “NP38625 Compounded Aseptic Medicines” is a framework: the contest is a place on its panel, up to 4 suppliers, not a single contract.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Cancelled
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
No (one-off requirement)
First published
30 Jul 2025, 10:34 BST
Last source update
23 Dec 2025, 11:20 GMT
Award evaluation window
1 Sept 2025 – …
FTS notice number
2025/S 000-085742
Classification (CPV)
Pharmaceutical products
Delivery area
Scotland (UKM)
Official registry OCID
ocds-h6vhtk-0568b2 Find a Tender
Contract terms
Electronic trading
e-invoicing allowed · electronic ordering · electronic payment
Review and risk notes
Review procedure

The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.

Publisher note: The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the thirty-six (36) month contract duration and the twelve (12) month extension period of the framework agreement. (SC Ref:819359)

How it was run

Official notice
Run through: Public Contracts Scotland · Who buys & how to bid on PCS
Supplier login requiredLanguage: EN
Access & registration note: Free single registration for Scotland; PCS-Tender (Jaggaer) for full bidding
Appointment period ends
1 Sept 2025, 12:00 BST
Submission channel
{"electronicSubmission"}
Accepted languages
en
Bid validity
90 days from the deadline
Bids opened
1 Sept 2025, 12:00 BST
Detailed submission instructions & authority contactsFrom official release

www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html ↗

Timeline

1 Sept 2025 → 23 Dec 2025 · 3 dates
  1. Admission / appointment period endsperiod end, not a bid countdown
    1 Sept 2025, 12:00 BST
  2. Bids opened
    1 Sept 2025, 12:00 BST
  3. Notice published309 days ago
    23 Dec 2025, 11:20 GMT

Notice history

1 event · 2 releases on Find a Tender
  1. Status changed to cancelled
    23 Dec 2025, 11:20 GMT

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 4

Contracting authority & participating public bodies

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contracting authorityNHS & healthcareBody governed by public lawHealth 1 South Gyle Crescent, Edinburgh, Scotland, EH12 9EBContact name, email, phone Published organisation website ↗

Dispute resolution & review bodies

  • Sheriff Court HouseReview body EdinburghContact email, phone

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.